| Price | $6.38 |
| Year Range | $3.66 – $7.57 |
| Market Cap | $242M |
| Industry | Drug Manufacturers |
What Is Lifecore Biomedical’s AI Stock Analysis?
Lifecore Biomedical’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Lifecore Biomedical’s momentum in near-real time.
Lifecore Biomedical (LFCR) has an AltIndex AI Score of 41/100, currently a Hold signal. The AI Score distills Lifecore Biomedical's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Lifecore Biomedical’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Lifecore Biomedical — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving LFCR’s AI Score?
Technicals
Today's stock price is $6.38. This is an increase of 43.05% compared to a month ago, indicating a positive short-term trend. However, compared to a year ago, there is a decrease of 1.69%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $6.43, which is lower than the previous SMA10 of $6.44. This suggests a potential downward trend in price movement. The RSI is 88.9, indicating a potentially overbought (bearish) condition.
See the full technical analysis and price prediction.
Alternative data
Lifecore Biomedical has an estimated 0 open positions. This number is down by -100% in the last couple of months, indicating a company trying to improve its margins or cut costs. Not a great sign for a growing company. The business outlook among employees at Lifecore Biomedical is low (an estimate of only 36% of employees have a positive outlook), a concerning sign. Lifecore Biomedical has an estimate of 4,000 visitors to their webpage. The number of visitors is down by -50% in the last couple of months, a worrisome trend as this can indicate a loss in customers.
Explore Lifecore Biomedical’s job postings, web traffic and app downloads.
Frequently Asked Questions: Lifecore Biomedical AI Stock Analysis
Lifecore Biomedical's AltIndex AI Score is 41/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Lifecore Biomedical a Hold (41/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Lifecore Biomedical — company overview, fundamentals, technicals and alternative data, with a recommendation. See the LFCR AI Score or sign up to read the full thesis.
